We're pleased that you plan to submit your article! Before starting your submission, please check that this journal's publishing policy is compatible with your and your co-authors' funding agreements. Taylor & Francis requires you to delay making an Accepted Manuscript version of your article available if you are not publishing Open Access.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Publish Open Access Finland]({"type":"image" , "src" : "/sda/110396/JournalAd-OA-Agreements.gif"})
![Dialogues in Clinical Neuroscience is now a fully Open Access journal]({"type":"image" , "src" : "/sda/111031/JournalAd-Announce-Neuroscience.jpg"})
![Human vaccines & Immunotherapeutics is now a fully Open Access journal]({"type":"image" , "src" : "/sda/111078/JournalAd-Announce-Immunology.jpg"})
Preview
Freeing a patient from the clutches of thoughts and behaviors that are all-consuming is the goal in management of obsessive-compulsive disorder. Dr Casey discusses characteristic features and a pharmacologic approach to management, looking at several agents that have shown great promise in suppressing symptoms. A representative case is included.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
